[{"Assets_0_Q2_USD":1724237000.0,"CommonStockSharesOutstanding_0_Q2_shares":86103000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":171480000.0,"NetIncomeLoss_2_Q2_USD":228387000.0,"NetIncomeLoss_1_Q2_USD":125706000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":86210000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":86215000.0,"StockholdersEquity_0_Q2_USD":171246000.0,"EarningsPerShareBasic_1_Q2_USD":1.46,"EarningsPerShareBasic_2_Q2_USD":2.65,"Ticker":"IDXX","CIK":"874716","name":"IDEXX LABORATORIES INC \/DE","OfficialName":"IDEXX Laboratories Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"42180715521.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"SP500","filed":"20190801"}]